| human | Q5 |
| P8168 | FactGrid item ID | Q888126 |
| P227 | GND ID | 132405156 |
| P2671 | Google Knowledge Graph ID | /g/121v79_l |
| P213 | ISNI | 0000000382766626 |
| P10553 | IxTheo authority ID | 52267593X |
| P3413 | Leopoldina member ID (superseded) | 1528 |
| P244 | Library of Congress authority ID | n88067231 |
| P8189 | National Library of Israel J9U ID | 987007384237805171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 072524855 |
| P496 | ORCID iD | 0000-0002-2324-5444 |
| P214 | VIAF ID | 266910835 |
| P10832 | WorldCat Entities ID | E39PBJhdbPCMMCf38qyFtmTGpP |
| P27 | country of citizenship | Germany | Q183 |
| P108 | employer | University of Jena | Q154561 |
| P735 | given name | Konrad | Q18156186 |
| Konrad | Q18156186 | ||
| P1412 | languages spoken, written or signed | German | Q188 |
| P463 | member of | German Academy of Sciences Leopoldina | Q543804 |
| P1559 | name in native language | Konrad Reinhart | |
| P106 | occupation | physician | Q39631 |
| university teacher | Q1622272 | ||
| P21 | sex or gender | male | Q6581097 |
| P937 | work location | Jena | Q3150 |
| Q34545603 | "Euthanasia": A confusing term, abused under the Nazi regime and misused in present end-of-life debate |
| Q34527815 | A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis - A Prospective Multicenter Phase II Diagnostic Study |
| Q35327943 | A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psychometric testing |
| Q36787258 | A positive fluid balance is associated with a worse outcome in patients with acute renal failure |
| Q35568819 | Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions |
| Q33751750 | Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis |
| Q34026878 | Anemia and blood transfusion in a surgical intensive care unit |
| Q35609421 | Barriers and supportive conditions to improve quality of care for critically ill patients: A team approach to quality improvement. |
| Q35217267 | Catecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey |
| Q35751235 | Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. |
| Q35852242 | Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary |
| Q33525469 | Characterization of buccal microvascular response in patients with septic shock. |
| Q36449421 | Concerns over use of hydroxyethyl starch solutions |
| Q36108698 | Crossing the handover chasm: Clinicians' perceptions of barriers to the early detection and timely management of severe sepsis and septic shock |
| Q36749132 | Diagnosis of ventilator-associated pneumonia: a systematic review of the literature |
| Q21195047 | Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature |
| Q34280888 | Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial |
| Q44506875 | Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial |
| Q33752989 | End-stage renal disease and outcome in a surgical intensive care unit |
| Q34430579 | Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. |
| Q35041304 | Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study |
| Q21194917 | Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry |
| Q36220284 | Has mortality from acute renal failure decreased? A systematic review of the literature |
| Q33396794 | Heparin-induced thrombocytopenia type II in a surgical intensive care unit |
| Q28264225 | Hydrocortisone therapy for patients with septic shock |
| Q35481179 | Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock |
| Q33754099 | Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study |
| Q96642106 | Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis |
| Q28264234 | Intensive insulin therapy and pentastarch resuscitation in severe sepsis |
| Q28193956 | Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study |
| Q34633607 | Markers of endothelial damage in organ dysfunction and sepsis |
| Q42741920 | Moderate-dose vasopressin therapy may impair gastric mucosal perfusion in severe sepsis: a pilot study |
| Q35559416 | Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study |
| Q34303687 | New approaches to sepsis: molecular diagnostics and biomarkers. |
| Q36754408 | Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension |
| Q35561206 | Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated). |
| Q96580100 | Re: Clinical Trials in Volume Resuscitation with Hydroxyethyl Starch: Focus on Risk of Bias |
| Q36993153 | Readmission to a surgical intensive care unit: incidence, outcome and risk factors |
| Q36301051 | Relatives' perception of stressors and psychological outcomes - Results from a survey study. |
| Q24644984 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 |
| Q29615602 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 |
| Q28284276 | Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 |
| Q40118119 | The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. |
| Q24795268 | The PIRO concept: R is for response |
| Q33679447 | The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis |
| Q36286143 | The Validity of Advance Directives in Acute Situations |
| Q33653312 | The burden of sepsis: a call to action in support of World Sepsis Day 2013 |
| Q28253821 | The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock |
| Q36070469 | The late phase of sepsis is characterized by an increased microbiological burden and death rate |
| Q36146621 | The value of venous oximetry |
| Q42420218 | To transfuse or not to transfuse: thinking outside the box. |
| Q33219818 | Transcription in response to physical stress--clues to the molecular mechanisms of exercise-induced asthma |
| Q64240076 | Understanding the Harms of HES: A Review of the Evidence to Date |
| Q36152823 | Venous oximetry |
| Konrad Reinhart | wikipedia |
Search more.